Multi-Therapeutic Sites with Unique and Highly Effective Trial Capabilities and Expertise
Our proficient and experienced team members engage quickly and provide strategic thinking to execute on vaccine trials. This ensures faster start-up times and efficient delivery on every vaccine study.
With the diverse populations surrounding our sites, Accel provides the ability to recruit for all types of vaccine studies, from healthy subjects to specialty populations. Accel sites are experienced at vaccine studies for adult, elderly and adolescent populations.
Featuring a growing database of over 50,000 subjects, a dedicated marketing team, and a bilingual recruiting call center, Accel sites have continually proven successful in recruiting high-volume studies. Typical vaccine studies start with a detailed recruitment strategy review. Working in tandem with the sponsor or CRO, Accel’s marketing team develops a detailed, targeted marketing plan that typically incorporates TV, radio, print and online media outlets. The recruiting team works closely with the marketing team to filter the database of subjects interested in trial participation, based on the study’s inclusion and exclusion criteria. This process successfully delivers quality subjects in a short timeframe.
What differentiates Accel Research Sites from other vaccine research sites is our ability to excel at conducting protocols with complex procedure requirements. Whether the study requires overnight stays, an IV infusion or significant serology draws, the need for the proper facilities and experience is critical to the success of these trials. Accel offers 3 fully-equipped and specialized sites to support a high volume of patient visits, including bed space for possible extended day or overnight requirements.